Tapewire

Nasdaq · USD

AGIO

AGIOS PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
4499
SEC CIK
0001439222
Parsed reports
520

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202506
Jan 202601
Feb 202600
Mar 2026021
Apr 202607
May 202600
Jun 202600
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 18, 2026 Filed Jun 23, 2026 21:14 UTC
Jones CeciliaChief Financial Officer
GrantRestricted stock units · Derivative 3,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000083 · wk-form4_1782249240.xml · derivative · entry 2

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common stock · 3,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: Performance stock units were granted on March 1, 2025, and provide for the vesting of underlying shares upon the achievement of three specified clinical and research milestones established by the compensation & people committee, or board of directors, as applicable. The performance criteria for the specified research milestone was determined by the compensation & people committee to be met as of June 18, 2026. The shares related to such milestone will vest on December 31, 2027, subject to the recipient's continued service.

F2 · derivative.expiration_date: Performance stock units were granted on March 1, 2025, and provide for the vesting of underlying shares upon the achievement of three specified clinical and research milestones established by the compensation & people committee, or board of directors, as applicable. The performance criteria for the specified research milestone was determined by the compensation & people committee to be met as of June 18, 2026. The shares related to such milestone will vest on December 31, 2027, subject to the recipient's continued service.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:14 UTC
Jones CeciliaChief Financial Officer
Exercise / conversionPerformance share units · Derivative 3,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000083 · wk-form4_1782249240.xml · derivative · entry 1

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: Performance stock units were granted on March 1, 2025, and provide for the vesting of underlying shares upon the achievement of three specified clinical and research milestones established by the compensation & people committee, or board of directors, as applicable. The performance criteria for the specified research milestone was determined by the compensation & people committee to be met as of June 18, 2026. The shares related to such milestone will vest on December 31, 2027, subject to the recipient's continued service.

F2 · derivative.expiration_date: Performance stock units were granted on March 1, 2025, and provide for the vesting of underlying shares upon the achievement of three specified clinical and research milestones established by the compensation & people committee, or board of directors, as applicable. The performance criteria for the specified research milestone was determined by the compensation & people committee to be met as of June 18, 2026. The shares related to such milestone will vest on December 31, 2027, subject to the recipient's continued service.

Read SEC document
June 13, 2026 Filed Jun 16, 2026 20:09 UTC Exercise / conversionRestricted stock units · Derivative 1,976 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000077 · wk-form4_1781640580.xml · derivative · entry 2

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 1,976 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 13, 2026 Filed Jun 16, 2026 20:09 UTC Exercise / conversionCommon stock 1,976 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000077 · wk-form4_1781640580.xml · nonDerivative · entry 1

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2026 Filed Jun 16, 2026 20:06 UTC Exercise / conversionRestricted stock units · Derivative 1,976 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000075 · wk-form4_1781640401.xml · derivative · entry 2

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 1,976 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 13, 2026 Filed Jun 16, 2026 20:06 UTC Exercise / conversionCommon stock 1,976 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000075 · wk-form4_1781640401.xml · nonDerivative · entry 1

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:07 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionPerformance share units · Derivative 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000061 · wk-form4_1775506037.xml · derivative · entry 3

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common stock · 8,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F3 · derivative.expiration_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:07 UTC
Milanova TsvetaChief Commercial Officer
SaleCommon stock 3,262 $34.71 $113,224.02
Disclosure

SEC source: 0001439222-26-000061 · wk-form4_1775506037.xml · nonDerivative · entry 2

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,829

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:07 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionCommon stock 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000061 · wk-form4_1775506037.xml · nonDerivative · entry 1

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:10 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionPerformance share units · Derivative 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000065 · wk-form4_1775506198.xml · derivative · entry 3

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common stock · 8,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F4 · derivative.expiration_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:10 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 2,940 $34.71 $102,047.40
Disclosure

SEC source: 0001439222-26-000065 · wk-form4_1775506198.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,277

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:10 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000065 · wk-form4_1775506198.xml · nonDerivative · entry 1

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 311 shares purchased through the Company's employee stock purchase plan.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:11 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionPerformance share units · Derivative 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000067 · wk-form4_1775506306.xml · derivative · entry 3

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common stock · 8,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F3 · derivative.expiration_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:11 UTC
Burns James WilliamChief Legal Officer
SaleCommon stock 3,280 $34.71 $113,848.80
Disclosure

SEC source: 0001439222-26-000067 · wk-form4_1775506306.xml · nonDerivative · entry 2

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,306

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:11 UTC
Burns James WilliamChief Legal Officer
Exercise / conversionCommon stock 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000067 · wk-form4_1775506306.xml · nonDerivative · entry 1

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:08 UTC
Jones CeciliaChief Financial Officer
Exercise / conversionPerformance share units · Derivative 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000063 · wk-form4_1775506133.xml · derivative · entry 3

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common stock · 8,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F4 · derivative.expiration_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:08 UTC
Jones CeciliaChief Financial Officer
SaleCommon stock 3,141 $34.71 $109,024.11
Disclosure

SEC source: 0001439222-26-000063 · wk-form4_1775506133.xml · nonDerivative · entry 2

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,998

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:08 UTC
Jones CeciliaChief Financial Officer
Exercise / conversionCommon stock 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000063 · wk-form4_1775506133.xml · nonDerivative · entry 1

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 311 shares purchased through the Company's employee stock purchase plan.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:05 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
Exercise / conversionPerformance share units · Derivative 8,100 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000059 · wk-form4_1775505928.xml · derivative · entry 3

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,100

Underlying: Common stock · 8,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The PSUs were granted on March 5, 2025. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F3 · derivative.expiration_date: The PSUs were granted on March 5, 2025. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:05 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
SaleCommon stock 2,959 $34.71 $102,706.89
Disclosure

SEC source: 0001439222-26-000059 · wk-form4_1775505928.xml · nonDerivative · entry 2

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,282

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 5, 2025.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:05 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
Exercise / conversionCommon stock 8,100 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000059 · wk-form4_1775505928.xml · nonDerivative · entry 1

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionPerformance share units · Derivative 13,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · derivative · entry 6

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,500

Underlying: Common stock · 13,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F5 · derivative.exercise_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 25% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 75% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 25% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F5 · derivative.expiration_date: The PSUs were granted on March 1, 2024. The PSUs vest as to 25% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 75% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 25% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionPerformance share units · Derivative 25,528 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · derivative · entry 5

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 25,528 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The PSUs were granted on August 8, 2022. The PSUs vest as to 15% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining underlying shares upon the achievement of other clinical and regulatory milestones. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 15% of the underlying shares of common stock. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F4 · derivative.expiration_date: The PSUs were granted on August 8, 2022. The PSUs vest as to 15% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining underlying shares upon the achievement of other clinical and regulatory milestones. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 15% of the underlying shares of common stock. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
SaleCommon stock 6,596 $34.71 $228,947.16
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · nonDerivative · entry 4

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,508

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionCommon stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · nonDerivative · entry 3

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
SaleCommon stock 12,472 $34.71 $432,903.12
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · nonDerivative · entry 2

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,604

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated August 8, 2022.

Read SEC document
April 02, 2026 Filed Apr 6, 2026 20:04 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionCommon stock 25,528 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000057 · wk-form4_1775505863.xml · nonDerivative · entry 1

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:12 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
Exercise / conversionRestricted stock units · Derivative 8,100 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000049 · wk-form4_1773087128.xml · derivative · entry 3

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,200

Underlying: Common stock · 8,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:12 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
SaleCommon stock 2,959 $27.80 $82,260.20
Disclosure

SEC source: 0001439222-26-000049 · wk-form4_1773087128.xml · nonDerivative · entry 2

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,141

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 5, 2025.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:12 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
Exercise / conversionCommon stock 8,100 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000049 · wk-form4_1773087128.xml · nonDerivative · entry 1

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:08 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 5,272 $28.88 $152,255.36
Disclosure

SEC source: 0001439222-26-000046 · wk-form4_1772744891.xml · nonDerivative · entry 1

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 868

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionRestricted stock units · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · derivative · entry 8

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F7 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F7 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionRestricted stock units · Derivative 5,666 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · derivative · entry 7

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,667

Underlying: Common stock · 5,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F6 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F6 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
SaleCommon stock 1,187 $28.96 $34,375.52
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · nonDerivative · entry 4

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,591

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionCommon stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · nonDerivative · entry 3

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,778

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
SaleCommon stock 1,681 $28.96 $48,681.76
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · nonDerivative · entry 2

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,778

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:13 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionCommon stock 5,666 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000036 · wk-form4_1772572436.xml · nonDerivative · entry 1

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · derivative · entry 12

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F9 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F9 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 5,666 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · derivative · entry 11

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,667

Underlying: Common stock · 5,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F8 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F8 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · derivative · entry 10

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F7 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

F7 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,187 $28.96 $34,375.52
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 6

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,406

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 5

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,681 $28.96 $48,681.76
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 4

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,593

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 5,666 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 3

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,274

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,187 $28.96 $34,375.52
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,608

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:15 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionCommon stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000040 · wk-form4_1772572555.xml · nonDerivative · entry 1

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:17 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionRestricted stock units · Derivative 13,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000044 · wk-form4_1772572669.xml · derivative · entry 11

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common stock · 13,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F9 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F9 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:17 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionRestricted stock units · Derivative 18,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000044 · wk-form4_1772572669.xml · derivative · entry 10

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common stock · 18,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F8 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F8 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:17 UTC
Goff BrianDirector · Chief Executive Officer
Exercise / conversionRestricted stock units · Derivative 8,500 $0.00 $0.00
Disclosure

SEC source: 0001439222-26-000044 · wk-form4_1772572669.xml · derivative · entry 9

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 8,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F7 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

F7 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:17 UTC
Goff BrianDirector · Chief Executive Officer
SaleCommon stock 5,918 $28.96 $171,385.28
Disclosure

SEC source: 0001439222-26-000044 · wk-form4_1772572669.xml · nonDerivative · entry 6

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,548

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.